Careers

A New Hope in the Battle Against Fatty Liver Disease: Understanding Rezdiffra™ (resmetirom)

A New Hope in the Battle Against Fatty Liver Disease: Understanding Rezdiffra™ (resmetirom)

March 14, 2024 | By | Clinical Research, Clinical Trials, Liver, Liver Disease, Liver Health, NASH, News & Events

Today, we’re talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic Steatohepatitis (NASH) a condition where too much fat is stored in the liver, causing inflammation and damage. NASH is a tricky disease because it’s often …

Rezdiffra™ (resmetirom) and NASH: A Promising Advance in Treatment

Rezdiffra™ (resmetirom) and NASH: A Promising Advance in Treatment

March 14, 2024 | By | News & Events, Clinical Trials, Liver, Liver Disease, Liver Health, NASH | Promising Advance in Treatment, resmetirom, Rezdiffra

Nonalcoholic Steatohepatitis (NASH) (now known as Metabolic Dysfunction-Associated Steatohepatitis or MASH) represents a significant and growing challenge in clinical practice, with its progression to cirrhosis and hepatocellular carcinoma posing serious risks for patients. The exciting new conditional commercial launch of …

Obesity can lead to liver disease. Find out why in our blog!

The Consequences of Obesity on the Liver

February 24, 2023 | By | Liver, NASH | Blog, Clinical trials, Fatty Liver Disease, Fibroscan, Liver disease, liver health

Obesity has become one of the most common and serious public health issues in recent years, leading to many health problems. Yet, many remain unaware of the consequences of obesity on the liver. Learn more in our blog below! Excess …

Are NASH and Cirrhosis Related?

NASH and Cirrhosis

July 1, 2022 | By | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research

At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …

Jaundice: A Complication of NASH

Jaundice: A Complication of NASH

May 31, 2022 | By | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications

Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …

NASH a modern lifestyle disease

NASH: A Modern Lifestyle Disease

November 24, 2020 | By | Clinical Trials, NAFLD, NASH | Blog, fatty liver, Fibroscan

  Every liver has a small amount of fat in it. With fatty liver, unhealthy fat levels begin to accumulate, leading to liver damage if not treated. There are various types of fatty liver disease, but NAFLD (non-alcoholic fatty liver …